). Moreover, CHI3L1 is also suggested as a cancer biomarker elevated in the sera of patients with of CHI3L1 structure as the residue corresponding to Asn (residue 60) does not exist in
為了持續優化網站功能與使用者體驗,本網站將Cookies分析技術用於網站營運、分析和個人化服務之目的。
若您繼續瀏覽本網站,即表示您同意本網站使用Cookies。